cilostazol and Coronary Vasospasm studies

cilostazol and Coronary Vasospasm

cilostazol has been researched along with Coronary Vasospasm in 2 studies

Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.

Research Excerpts

Excerpt	Relevance	Reference
"Cilostazol is an effective therapy for patients with VSA uncontrolled by conventional amlodipine therapy, and has no serious side effects."	2.79	A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. ( Hong, YJ; Jeong, YH; Kim, JH; Kim, JS; Kim, MH; Lee, CW; Lee, JH; Lee, JY; Nam, CW; Park, Y; Shin, ES; Shin, HK; Tahk, SJ; Yoo, SY, 2014)
"Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic adenosine monophosphate (cAMP) contents."	1.39	Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. ( Chun, KJ; Kim, J; Kim, JH; Kim, JS; Lee, JH; Park, YH; Shin, ES; Song, SG; Yoo, SY, 2013)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Shin, ES	2
Lee, JH	2
Yoo, SY	2
Park, Y	1
Hong, YJ	1
Kim, MH	1
Lee, JY	1
Nam, CW	1
Tahk, SJ	1
Kim, JS	2
Jeong, YH	1
Lee, CW	1
Shin, HK	1
Kim, JH	2
Song, SG	1
Park, YH	1
Kim, J	1
Chun, KJ	1

Studies

Shin, ES

Lee, JH

Yoo, SY

Park, Y

Hong, YJ

Kim, MH

Lee, JY

Nam, CW

Tahk, SJ

Kim, JS

Jeong, YH

Lee, CW

Shin, HK

Kim, JH

Song, SG

Park, YH

Kim, J

Chun, KJ

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of PletaalÒ(Cilostazol) in Subjects With Vasospastic Angina (STELLA)[NCT01444885]	Phase 2	50 participants (Actual)	Interventional	2011-10-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of PletaalÒ(Cilostazol) in Subjects With Vasospastic Angina (STELLA)[NCT01444885]

Phase 2

50 participants (Actual)

Interventional

2011-10-31

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for cilostazol and Coronary Vasospasm

Article	Year
A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. Heart (British Cardiac Society), 2014, Volume: 100, Issue:19 Topics: Adult; Angina Pectoris; Chest Pain; Cilostazol; Coronary Vasospasm; Dose-Response Relationship, Drug	2014

Article

Year

A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina.

Heart (British Cardiac Society), 2014, Volume: 100, Issue:19

Topics: Adult; Angina Pectoris; Chest Pain; Cilostazol; Coronary Vasospasm; Dose-Response Relationship, Drug

2014

Other Studies

1 other study available for cilostazol and Coronary Vasospasm

Article	Year
Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. Cardiovascular therapeutics, 2013, Volume: 31, Issue:3 Topics: Adult; Aged; Angina Pectoris; Cilostazol; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Pho	2013

Article

Year

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

Cardiovascular therapeutics, 2013, Volume: 31, Issue:3

Topics: Adult; Aged; Angina Pectoris; Cilostazol; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Pho

2013